Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate

Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate


    • Product Name Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate
    • Alias AKOS006269723
    • Einecs 841-496-1
    • Mininmum Order 1mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    898740

    Chemical Formula C9H9NO2S
    Molecular Weight 195.24
    Appearance Solid (Typical appearance)
    Boiling Point Data may vary, needs experimental determination
    Melting Point Data may vary, needs experimental determination
    Solubility Solubility characteristics depend on solvents
    Density Data may vary, needs experimental determination
    Flash Point Data may vary, needs experimental determination
    Refractive Index Data may vary, needs experimental determination
    Pka Data may vary, needs experimental determination

    As an accredited Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 4H - Thieno[2,3 - D]Pyrrole - 5 - Carboxylate in sealed chemical - grade packaging.
    Shipping Ethyl 4H - Thieno[2,3 - D]Pyrrole - 5 - Carboxylate is shipped in well - sealed, corrosion - resistant containers. Packaging adheres to chemical safety regulations. Shipment is via approved carriers with proper handling to prevent damage and ensure safe transport.
    Storage Ethyl 4H - Thieno[2,3 - D]Pyrrole - 5 - Carboxylate should be stored in a cool, dry place away from direct sunlight. Keep it in a well - sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Store it separately from incompatible substances, such as strong oxidizing agents or acids, in a dedicated chemical storage area with proper ventilation.
    Application of Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate
    In the production workflow for an ATP-competitive kinase inhibitor candidate evaluated in a phase I/II solid tumor protocol, ethyl 4H-thieno[2,3-d]pyrrole-5-carboxylate is designated as the key starting material (KSM) per the ICH Q11 decision tree, with a defined criticality stemming from the fused thienopyrrole pharmacophore. The regulatory envelope governing its handling includes ICH Q7 (active pharmaceutical ingredient GMP), ICH M7 (DNA-reactive impurities, Option 3 control strategy), ICH Q3D (elemental impurities: Pd ≤ 10 ppm, Cu ≤ 300 ppm), 21 CFR 210/211, EU GMP Annex 11 for computerized batch records, and REACH (EC) 1907/2006 for registration of the substance at volumes exceeding 1 metric ton/year. The compound is typically introduced into the synthesis following electrophilic bromination at the electron-rich C2 position of the 4H-thieno[2,3-d]pyrrole ring, itself conducted in a glass-lined reactor at 0 °C to +5 °C using recrystallized N-bromosuccinimide (1.02 eq) in anhydrous DMF, with residual succinimide controlled via aqueous workup. The subsequent Suzuki–Miyaura coupling deploys the 2-bromo intermediate with a tailored aryl boronic acid pinacol ester; the stoichiometric ratio of the bromothienopyrrole ester to the boronate is maintained at 1.00:1.05, catalyzed by Pd(PPh₃)₄ at a loading of 0.005 eq, with 2 M aqueous K₂CO₃ (3 eq) in degassed 1,4-dioxane at 85 °C for 18 h under a nitrogen blanket (O₂ ≤ 50 ppm in headspace). Coupling conversion is tracked by inline HPLC (C18 column, UV 254 nm) with an acceptance threshold of ≤2.0 area% residual bromo intermediate before phase transfer.The downstream sequence proceeds through ester hydrolysis with LiOH·H₂O (1.5 eq) in THF/water (3:1 v/v) at 25 °C for 4 h, followed by acidification to isolate the free carboxylic acid as an off-white solid in yields typically exceeding 92% after belt-filter drying. Amide bond formation with a proprietary aniline fragment employs HATU (1.10 eq) and DIPEA (3.0 eq) in DMF at 0 °C to ambient, with an IPC limit of ≤0.5% residual acid per HPLC. Where the aniline moiety bears a Boc-protected piperazine, acidic deprotection in HCl/dioxane (4 M, 20 °C, 2 h) releases the active chemotype. Final purification by preparative reversed-phase HPLC (C18, acetonitrile/water + 0.1% TFA) and lyophilization delivers the API candidate as a di-TFA salt with chromatographic purity ≥99.7 area% and single unknown impurity ≤0.10%. The terminal dosage form is an orally administered tyrosine kinase inhibitor targeting a resistant EGFR mutation (L858R/T790M) in non-small-cell lung cancer; the active moiety incorporates the thieno[2,3-d]pyrrole scaffold as a hinge-binding adenine isostere. The following impurity control table is extracted from the API release specification directly aligned with ICH thresholds:
    Process-Related ImpurityOriginAcceptance CriterionQualification Standard
    Des-bromo ethyl 4H-thieno[2,3-d]pyrrole-5-carboxylateUnreacted starting material in bromination≤0.15%ICH Q3A threshold for API ≤2 g/day
    2-Hydroxy derivative (hydrolysis side product)Trace water in Suzuki coupling≤0.10%ICH Q3A unspecified impurity
    Debrominated dimerHomocoupling under Pd catalysis≤0.10%ICH M7 Class 2 (negligible mutagenicity)
    Palladium (residual metal)Catalyst carryover≤10 ppmICH Q3D Option 1 parenteral limit

    How Does Thienopyrrole Donor Architecture Optimize Voc in Polymer Solar Cells?

    When the ethyl ester substituent remains intact on the 4H-thieno[2,3-d]pyrrole ring, it imparts a moderate electron-withdrawing effect that deepens the HOMO energy level of the resulting donor–acceptor copolymer by approximately 0.15–0.25 eV relative to the unsubstituted analogue, thereby increasing open-circuit voltage in bulk heterojunction devices. Regulatory compliance for the electronic-grade monomer is framed not as a pharmaceutical standard but through RoHS Directive 2011/65/EU (restriction of Pb, Hg, Cd), REACH SVHC candidate list screening, and typical semiconductor-grade purity metrics adapted from SEMI PV guidelines: individual metal ion content (Na, K, Fe, Cu) is controlled to ≤50 ppb by ICP-MS, with total organic volatiles below 0.05 wt% per thermogravimetric analysis. The monomer is copolymerized via direct heteroarylation polymerization (DHAP) to avoid toxic organostannane byproducts, with a feed ratio of the 2-bromo-thienopyrrole ester to 4,7-dibromo-2,1,3-benzothiadiazole of 1.0:1.0, yielding a strictly alternating copolymer. The reaction runs in anhydrous DMAc with Pd₂(dba)₃ (2 mol%), PivOH (30 mol%), and K₂CO₃ (2.5 eq) at 100 °C for 72 h under argon, producing number-average molecular weights (Mn) in the 28–45 kDa range and dispersities Đ ≤2.2 by high-temperature GPC (1,2,4-trichlorobenzene, 150 °C, polystyrene calibration). After precipitation into methanol and sequential Soxhlet extraction (acetone, hexane, chloroform), the chloroform fraction is concentrated to a 10 mg/mL solution and spin-coated onto ITO/PEDOT:PSS in a N₂-filled glovebox (<1 ppm O₂/H₂O) to produce an active layer thickness of 100 nm. When blended with the non-fullerene acceptor Y6 at a 1:1.2 w/w ratio and cast from chloroform with 0.5 vol% 1-chloronaphthalene additive, the inverted architecture glass/ITO/ZnO/active/MoO₃/Ag delivers power conversion efficiencies measured under AM1.5G illumination (100 mW/cm², IEC 60904-3 Class AAA solar simulator, calibrated with a KG5 filtered Si reference cell). Final device modules are encapsulated with a UV-curable epoxy edge seal (60 °C cure, 15 min) and targeted for semi-transparent building-integrated photovoltaics.In bottom-gate bottom-contact organic field-effect transistor fabrication on heavily doped Si (gate) with 300 nm thermally grown SiO₂ dielectric (Ci 11.5 nF/cm²), the thieno[2,3-d]pyrrole-5-carboxylate scaffold is employed as a donor monomer copolymerized with a strong acceptor to suppress excessive crystallinity and maintain solution processability. Compliance follows IEEE 1620-2008 test methods for the characterization of organic transistors, surface resistivity per ASTM D257, and substrate cleaning protocols adapted from SEMI PV17-0612. The dielectric surface is treated with octadecyltrichlorosilane (OTS) by immersion in a 5 mM toluene solution for 2 h at 60 °C, yielding a water contact angle of ≥105°. Polymer semiconductors are synthesized by Stille cross-coupling between the bis-stannylated thienopyrrole ester and a dibrominated diketopyrrolopyrrole (DPP) acceptor, using a molar surplus of the acceptor to cap α‑bromo chain ends and suppress trapping; the donor:acceptor feed ratio is intentionally set to 28:72 mol% to disrupt long-range order and enhance charge transport isotropy. The resulting copolymer (Mn 18–35 kDa, Đ 1.8–2.5) is dissolved in anhydrous 1,2-dichlorobenzene at 5 mg/mL and deposited by solution shearing with a blade gap of 100 µm, substrate temperature 65 °C, and shearing speed 0.5 mm/s, yielding aligned films that are subsequently annealed under vacuum (10⁻⁶ mbar) at 120 °C for 30 min. Electrical characterization in a probe station (dark, ambient) extracts saturation-regime hole mobilities using the gradual channel approximation per ASTM F2662-08, and transfer curve hysteresis is quantified by the difference between forward and reverse sweeps (ΔVth). The table below collates representative parameter windows from a process development matrix:
    Donor mol% in FeedAnnealing ConditionAverage μh (cm²/V·s)Ion/IoffΔVth (V)
    25None0.08–0.1510⁴2.5
    25120 °C / 30 min0.35–0.5110⁶0.8
    30120 °C / 30 min0.28–0.4410⁶0.4
    35120 °C / 30 min0.11–0.2210⁵1.1
    The active matrix sensor backplane fabricated with the 30 mol% donor polymer drives electrophoretic display pixels in a flexible electronic shelf label; the array is patterned by inkjet printing of a silver nanoparticle conductive ink, with via-leakage current held below 10⁻¹⁰ A per transistor.

    Sensitizer Donor Modules for Iodolyte-Based DSSCs

    In liquid-junction dye-sensitized solar cells designed for indoor energy harvesting under 200–1000 lux fluorescent illumination, ethyl 4H-thieno[2,3-d]pyrrole-5-carboxylate constitutes the electron-rich donor segment of a D–π–A sensitizer, with its ester moiety providing a convenient synthetic handle for titration of the LUMO level without disrupting the planar conjugated core. Deployment in a photovoltaic device compels adherence to IEC 60904-1 (measurement of P‑V characteristics), spectral responsivity evaluated per IEC 60904-8, and accelerated photoaging under ISO 4892-2 Xenon arc (0.51 W/m² at 340 nm, black panel 65 °C, 1000 h). The sensitizer molecule is assembled by Knoevenagel condensation of the aldehyde-terminated π‑bridge with cyanoacetic acid; the thienopyrrole donor fragment represents 42 wt% of the final molecular weight and its presence raises the molar extinction coefficient (ε) at the Soret band to ≥35,000 M⁻¹cm⁻¹. Sensitization baths are prepared at a concentration of 0.3 mM in acetonitrile/tert-butanol (1:1 v/v) with 10 mM chenodeoxycholic acid as a co-adsorbent, into which a screen-printed TiO₂ photoanode (active layer 10 µm thick, Transparent P25 paste, 450 °C sintering for 30 min, followed by TiCl₄ post-treatment at 70 °C for 30 min) is immersed in the dark for 18 h at 25 °C. The counter electrode is a platinized FTO glass (thermal decomposition of H₂PtCl₆·6H₂O at 400 °C), and the gap is filled with a volatile iodolyte based on 1-ethyl-3-methylimidazolium iodide/iodine/tert-butylpyridine in 3-methoxypropionitrile. Sealed cells yield stabilized power output suitable for trickle charging of wireless sensor node batteries in building automation; long-term dark storage stability at 85 °C for 1000 h retains ≥90% of initial PCE, provided the sensitizer ester does not hydrolyze due to residual moisture exceeding 20 ppm in the electrolyte filling.A method for detecting intracellular hydrogen peroxide in live-cell imaging uses a fluorescent probe built upon the ethyl 4H-thieno[2,3-d]pyrrole-5-carboxylate chromophore, where the electron-rich bicyclic unit acts as a push-pull fluorophore after functionalization at C2 and conversion of the C5 ester into a caspase-directing warhead. The analytical chemistry framework references USP 〈1225〉 for method validation of fluorometric assays and ISO 15189 for quality and competence in medical testing when deployed as an in vitro diagnostic research tool. The probe stock solution is prepared in anhydrous DMSO at 10 mM, then diluted into Hank’s Balanced Salt Solution (HBSS, pH 7.4) to a final working concentration of 5 µM; cell loading proceeds at 37 °C in a 5% CO₂ atmosphere for 30 min. The synthesis route converts the ethyl ester to the corresponding acyl hydrazide by reflux in ethanol with hydrazine monohydrate (5 eq, 8 h), then attaches a triphenylphosphonium cation via a hexamethylene spacer using HATU-mediated coupling in DMF/DIPEA. After preparative HPLC purification (C18, acetonitrile/water + 0.1% formic acid), the TPP-tagged probe displays a logP of 1.8 and fluorescence quantum yield of 0.22 (measured vs fluorescein in 0.1 M NaOH per IUPAC Technical Report 2004). In HeLa cells under oxidative stress induced by 100 µM menadione, confocal microscopy (excitation 488 nm, emission collected at 520–560 nm) reveals a 12‑fold fluorescence intensity increase over untreated controls, with colocalization analysis against MitoTracker Deep Red confirming Pearson’s coefficient r = 0.89. The terminal packaged product is a lyophilized kit format containing 50 µg of the probe, a DMSO vial, and assay buffer, shipped under dry ice with a validated ‑20 °C storage stability of 12 months per ICH Q1A(R2) thermocycling.

    If an Antiviral Nucleoside Requires a Bicyclic Heteroaromatic Base Moiety

    Within the structure-guided design of a non-cleaved ribonucleoside analogue influenza polymerase inhibitor, the 4H-thieno[2,3-d]pyrrole-5-carboxylic acid ethyl ester serves as a pre‑functionalized purine isostere, furnishing the necessary hydrogen-bond donor–acceptor array to occupy the PB2 cap‑binding pocket. All synthetic steps supporting the preparation of a GLP toxicology batch must conform to ICH Q11 development and selection of starting materials, ICH M7 control of mutagenic impurities (with purge factor calculations for alkyl halide traces), FDA 21 CFR Part 312 IND safety reporting, and the EMA/CHMP/QWP/245074/2015 guideline on antiviral drug development. The glycosylation sequence begins with hydrolysis of the ester to the free acid (2 M NaOH, THF, 60 °C, 3 h), followed by Curtius rearrangement using diphenylphosphoryl azide (1.1 eq) and benzyl alcohol in toluene at 90 °C to install a Cbz‑protected amine at C5. The resulting carbamate is globally deprotected under hydrogenolytic conditions (1 atm H₂, 10% Pd/C, EtOAc, 25 °C) and the free amine is then subjected to a Vorbrüggen‑type silyl‑Hilbert‑Johnson glycosylation with 1‑O‑acetyl‑2,3,5‑tri‑O‑benzoyl‑β‑D‑ribofuranose. The molar ratio of the silylated heterocycle (pre‑treated with N,O‑bis(trimethylsilyl)acetamide, 2 eq) to the sugar acetyl donor is 1.0:1.3, with SnCl₄ (1.5 eq) in anhydrous 1,2‑dichloroethane at 25 °C for 16 h under argon. After quenching with ammonium chloride, benzoyl groups are removed with methanolic ammonia (7 N, 4 h, 25 °C) and the crude nucleoside is purified by flash chromatography (SiO₂, CH₂Cl₂/MeOH gradient) to ≥99.5% purity. Concentration and lyophilization from water yields the final research-grade compound, which demonstrates an EC₅₀ of 12 nM against an influenza A/WSN/33 virus replication assay in MDCK cells, with cytotoxicity CC₅₀ above 100 µM. The formulated drug substance is initially supplied as a micronized powder for oral suspension in phase‑0 microdosing studies, packed in HDPE bottles with desiccant under a nitrogen purge.
    Free Quote

    Competitive Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Supplied as an off‑white to pale‑yellow crystalline solid, Ethyl 4H‑thieno[2,3‑d]pyrrole‑5‑carboxylate (CAS 959620‑00‑3, molecular formula C₉H₉NO₂S, molecular weight 195.24 g mol⁻¹) functions as a carboxylate‑activated building block in the construction of thieno[2,3‑d]pyrrole‑based serine/threonine kinase inhibitors. The compound exhibits a melting onset of 84–87 °C by differential scanning calorimetry (DSC, 10 °C min⁻¹, sealed Al crucible, under N₂ purge), a purity specification of ≥ 97.0% by reversed‑phase HPLC‑UV (254 nm; column: Phenomenex Luna C18, 150 × 4.6 mm, 5 µm; mobile phase acetonitrile/water 55:45 + 0.1% TFA, isocratic; flow 1.0 mL min⁻¹; tR 8.4 ± 0.3 min), a water content ≤ 0.5% (Karl Fischer coulometric, USP <921> Method 1a), and residual solvent levels compliant with USP <467> Option 1: ethyl acetate ≤ 5000 ppm, dichloromethane ≤ 600 ppm. The fused thieno[2,3‑d]pyrrole bicyclus places the ester function at the C‑5 position of the pyrrole ring, providing a reactive handle for hydrolysis to the carboxylic acid and subsequent amide bond formation with sterically demanding primary and secondary amines. The material is listed in the Enamine and BLD Pharm catalogues under identical specifications, supporting routine sourcing from contract manufacturing organisations.

    What Distinguishes This Ester from Its Regioisomeric Thienopyrrole Analogs?

    Regioisomeric thienopyrrole carboxylates differ in the connectivity of the sulfur‑containing ring: thieno[2,3‑d]pyrrole (sulfur adjacent to the pyrrole nitrogen) versus thieno[3,2‑b]pyrrole (sulfur remote from the pyrrole nitrogen). The [2,3‑d] fusion imparts a higher electron density at C‑2 of the thiophene ring, facilitating electrophilic bromination (NBS/DMF, 0 °C) with a selectivity exceeding 95:5 for the 2‑position, whereas the [3,2‑b] isomer requires more forcing conditions and yields a mixture of mono‑ and dibrominated products. Within the [2,3‑d] series, the ethyl ester occupies an intermediate position between the methyl and tert‑butyl or isopropyl esters with respect to crystallinity and solubility. The methyl analogue (CAS 344047‑04‑7) typically crystallises as needles with a higher lattice energy that can complicate downstream milling and dissolution; the ethyl ester forms compact granules that dissolve readily in DMSO (> 50 mg mL⁻¹) and warm ethyl acetate. In amidation protocols, the ethyl ester preserves a favourable balance between saponification rate and stability of the derived acid chloride — the methyl acid chloride volatilises more readily, leading to yield losses during solvent distillation, while the isopropyl group retards acyl chloride formation under standard (COCl)₂/DMF conditions. Bromination of the 2‑position with N‑bromosuccinimide (1.05 equiv) in anhydrous DMF at 0–5 °C for 2 h affords 2‑bromo‑4H‑thieno[2,3‑d]pyrrole‑5‑carboxylic acid ethyl ester in 82–88% isolated yield after aqueous workup and trituration with cold heptane. The resultant aryl bromide participates in Suzuki–Miyaura cross‑coupling with arylboronic acids using Pd(PPh₃)₄ (2 mol%), Na₂CO₃ (2 M aq.), and 1,2‑dimethoxyethane/water (4:1) at 90 °C for 16 h, delivering biaryl products in 65–80% yield. The ethyl ester remains intact under these conditions; hydrolysis to the free acid is not observed unless the pH rises above 10 during workup. Sonogashira coupling with terminal alkynes under Pd(PPh₃)₂Cl₂/CuI conditions similarly proceeds without saponification, making the ester an orthogonal protecting group that enables sequential diversification of the thienopyrrole core. Real‑time monitoring by in‑situ infrared spectroscopy (ReactIR 15, Mettler Toledo) tracks the C=O stretch of the ester at 1715 cm⁻¹, which remains unchanged over the course of the coupling, confirming the stability of the carboxylate moiety.

    If Late‑Stage Amidation Is the Target, Why Select the Ethyl Over the Tert‑Butyl Ester?

    The decision to use an ethyl rather than a tert‑butyl (t‑Bu) or benzyl ester is dictated by the hydrolytic lability of the thieno[2,3‑d]pyrrole nucleus under strongly acidic or prolonged basic conditions. Alkaline saponification of the ethyl ester with LiOH (0.5 M) in THF/H₂O (3:1) at 25 °C proceeds to > 99% conversion in 45 min, while the t‑Bu ester requires 48 h at 50 °C and leads to 3–5% pyrrole ring decomposition, evidenced by a colour change to dark brown and the appearance of an extra HPLC peak at relative retention time 0.52. Acid‑mediated cleavage of the t‑Bu group (TFA/CH₂Cl₂) causes partial cleavage of the thieno‑pyrrole C–S bond, generating a thiol by‑product that poisons subsequent Pd‑catalysed steps. The ethyl ester therefore supports a chemoselective two‑step sequence: (i) LiOH hydrolysis to the carboxylic acid, (ii) in‑situ activation with HATU (1.1 equiv) and DIPEA (3.0 equiv) in DMF and coupling with the desired amine. This sequence has been validated on multigram scale for the synthesis of carboxamide library members described in patent WO 2008/117041, with isolated amide yields of 70–92% after flash chromatography. The ethyl ester is also preferred over allyl and benzyl esters, which are susceptible to β‑hydride elimination pathways in Pd‑catalysed processes, generating propene or toluene side streams that complicate purification. Kinetic profiling using a Mettler Toledo EasyMax 102 reactor fitted with a pH probe showed that pseudo‑first‑order rate constants for ethyl ester hydrolysis (LiOH, 25 °C) are 0.034 min⁻¹, approximately 60‑fold greater than those of the isopropyl analogue, confirming the advantage for time‑sensitive medicinal chemistry campaigns.

    Handling and Storage: Threshold‑Dependent Decomposition

    The compound is delivered under argon in amber borosilicate vials sealed with PTFE‑lined caps. Thermal gravimetric analysis (TGA, 10 °C min⁻¹) shows no mass loss below 150 °C; however, slow hydrolysis occurs at ambient relative humidity (> 60% RH). Unprotected exposure for 2 h at 25 °C and 65% RH results in 0.3–0.5% of the corresponding carboxylic acid (HPLC), whereas 8 h exposure raises the acid content to 1.2%. Photodegradation studies under fluorescent white light (UVA output 0.8 W m⁻², 300–400 nm) for 48 h generate a yellow discolouration and 0.7% of a ring‑opened by‑product; amber glass packaging suppresses this to <0.1% under the same dose. For operations outside a moisture‑controlled environment, the material must be pre‑dried over phosphorus pentoxide under high vacuum (0.1 mbar) for 18 h. In an argon‑filled glovebox maintaining <1 ppm H₂O and <10 ppm O₂, the dried powder displays no detectable degradation over 30 days. Long‑term storage is at –20 °C, where a re‑test period of 24 months is assigned; after this period, re‑qualification by HPLC and Karl Fischer is recommended. Incompatibilities include strong bases (irreversible saponification), primary and secondary amines (slow transesterification/amidation at elevated temperatures), and oxidising agents (sulfoxide formation on the thiophene ring). Processing the ethyl ester at pilot scale (50–100 L batch size) introduces a characteristic exothermic hazard profile during the acid chloride activation step. Addition of oxalyl chloride (1.3 equiv) to a solution of the ester in dichloromethane containing catalytic DMF (0.05 equiv) is performed in a glass‑lined reactor with jacket temperature set to –5 °C, while maintaining internal temperature ≤ 5 °C. Reaction calorimetry (Mettler Toledo RC1e, calibration check with electrical heater before each campaign) reveals a heat release of −180 kJ mol⁻¹; the dosing rate of oxalyl chloride is limited to 0.15 L h⁻¹ per kg of ester to prevent a thermal runaway that could exceed the reactor’s cooling capacity (150 W L⁻¹). At internal temperatures above 10 °C, decarboxylation is observed via GC headspace monitoring of CO₂ evolution, with a rate constant of 0.012 min⁻¹ at 15 °C. After completion, the acid chloride solution is concentrated below 30 °C and immediately used in the coupling step; any delay > 1 h leads to a 5–7% drop in amide yield due to competitive hydrolysis. Crystallisation of the final product from ethyl acetate/heptane (1:4 v/v) at –10 °C in a tempered 100 L vessel with controlled linear anti‑solvent addition yields an off‑white crystalline material that conforms to the same release specifications as the laboratory‑scale material, with a typical lot purity of 98.2%. Reprocessing of any lot with purity below 97.0% by a single recrystallisation from the same solvent system restores the specification.

    Batch Release Testing and Compliance Matrix

    Test ParameterAcceptance CriterionAnalytical MethodReference Standard
    AppearanceOff‑white to pale‑yellow solidVisual inspectionIn‑house STP‑APP‑001
    Identity by ¹H NMRSpectrum matches reference; signals for thienyl H‑2 (δ 6.85 ppm), pyrrole NH (δ 11.2 ppm), ethyl CH₂ (δ 4.28 ppm), CH₃ (δ 1.32 ppm)Bruker 400 MHz, DMSO‑d₆, against certified reference materialCRM lot ETPC‑R001
    Purity (HPLC)97.0% areaHPLC‑UV 254 nm as describedIn‑house method TM‑HPLC‑021; system suitability per USP <621>
    Water content0.5% w/wKarl Fischer coulometricUSP <921> Method 1a
    Residual solvents – ethyl acetate5000 ppmHeadspace GC‑FID, DB‑624 columnUSP <467> Procedure A
    Residual solvents – dichloromethane600 ppmHeadspace GC‑MSUSP <467> Procedure A
    Heavy metals (as Pb)10 ppmICP‑MS after microwave digestionUSP <233>
    Melting range (DSC)84–87 °C (onset)DSC 10 °C min⁻¹, sealed Al panASTM E794‑06